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Interventions
Three strategies were examined. The first strategy involved treating all patients at the time of diagnosis, which meant there was no screening and patients started on ACE inhibitors (ramipril 10mg daily) when diagnosed with type 2 diabetes. The second strategy involved screening for microalbuminuria, once a year, with treatment if the result was positive. The third strategy was screening for macroalbuminuria, once a year, with treatment if the result was positive. Patients were switched to ARBs (irbesartan 300mg daily) if they developed an ACE inhibitor-related cough. These strategies were compared with no screening and no treatment.
Location/setting
Germany/primary care.
Methods

Analytical approach:
The analysis was based on a Markov model with a lifetime horizon. The authors stated that the perspective of a statutory health insurer was adopted.
Effectiveness data:
Various electronic databases were searched to identify relevant sources of evidence for the model. Some details on the search criteria and the design of the studies found in the literature were reported. Two meta-analyses providing evidence on the efficacy of ACE inhibitors in patients with type I and II diabetes were found in the Cochrane Database of Systematic Reviews and were used as the main source for efficacy data. The natural history of progression from diabetes to end-stage renal disease was based on several sources including the two meta-analyses already mentioned and other published clinical trials. Epidemiological data were based on German studies, when available.
Monetary benefit and utility valuations:
The utility values for diabetic patients were from a published cross-sectional study that included 292 patients interviewed using the time trade-off (TTO) method. The utility estimates for other health conditions were from a systematic review of empirical studies that used the TTO method.
